The Journal of Heart and Lung Transplantation
Volume 25, Issue 7 , Pages 756-764 , July 2006

Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart Failure

  • Leslie W. Miller, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Leslie W. Miller, MD, Cardiovascular Division, University of Minnesota, 420 Delaware Street SE, MMC 508, Minneapolis, MN 55455. Telephone: 612-626-2178. Fax: 612-626-4571.
    • ,
  • Katherine Lietz, MD, PhD

Received 27 December 2005 ,Revised 28 February 2006 ,Accepted 13 March 2006.

References 

  1. Miller LW , Missov E . The epidemic of heart failure . Cardiol Clin . 2001;19:547–555
  2. Hunt SA , et al.  American College of Cardiology  American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)   ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult (a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines) . JAMA . 2005;46: e1–82
  3. Redfield MM . Heart failure (an epidemic of uncertain proportions) . N Engl J Med . 2002;347:1142–1144
  4. Jessup M , Brozena S . Heart failure . N Engl J Med . 2003;348:2007–2018
  5. Nohria A , Lewis E , Stevenson LW . Medical management of advanced heart failure . JAMA . 2002;287:628–640
  6. Bardy G , Lee K , Mark D , et al.   Amiodarone or implantable cardio-defibrillator for congestive heart failure . N Engl J Med . 2005;352:225–237
  7. Moss A , Hall J , Cannom D , et al.   Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction . N Engl J Med . 2002;346:877–883
  8. Topol EJ . Current status and future prospects for acute myocardial infarction therapy . Circulation . 2003;108(suppl III):6–13
  9. American Heart Association . Heart disease and stroke statistics—2005 update . Dallas, TX: American Heart Association; 2005;
  10. Abraham WT , Adams K , Fonarrow GC  ADHERE Scientific Advisory Committee and Investigators . In hospital mortality in patients with advanced heart failure requiring intravenous vasoactive medications (an analysis from the ADHERE national registry) . J Am Coll Cardiol . 2005;46:57–64
  11. Vasan RS , Larson G , Levy DC . Congestive heart failure in subjects with normal versus decreased left ventricular ejection fraction (prevalence and outcomes in a population-based cohort) . J Am Coll Cardiol . 1999;33:1948–1955
  12. Senni M , Redfield MM . Heart failure with preserved systolic function (a different natural history?) . J Am Coll Cardiol . 2001;38:1277–1282
  13. O’Connell JB , Bristow MR . Economic impact of heart failure in the United States (time for a different approach) . J Heart Lung Transplant . 1994;13(suppl):107–112
  14. Mackowiak J . Cost of heart failure to the healthcare system . Am J Manag Care . 1998;4(suppl 6):338–342
  15. Taylor DO , Edwards LB , Boucek MM , et al.  Registry of the International Society for Heart and Lung Transplantation   twenty-first official adult heart transplant report . 2004;23:796–803
  16. Rose EA , Gelijns AC , Moskowitz AJ , et al.  Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) study group   Long-term mechanical left ventricular assistance for end-stage heart failure . N Engl J Med . 2001;345:1435–1443
  17. Lietz K , Miller LW . Will left ventricular assist device therapy replace heart transplantation in the foreseeable future? . Curr Opin Cardiol . 2005;20:132–137
  18. Miller LW . Limitations of current medical therapy for the treatment of heart failure . Rev Cardiovasc Med . 2003;4(suppl):21–29
  19. Lietz K , Miller LW . Left ventricular assist devices (evolving devices and indications for use) . Curr Opin Cardiol . 2004;19:613–618
  20. Stevenson LW , Shekar P . Ventricular assist devices for durable support . Circulation . 2005;112:111–115
  21. Stevenson LW , Rose EA . Left ventricular assist devices (bridges to transplantation, recovery, and destination for whom?) . Circulation . 2003;103:3059–3063
  22. Frazier OH , Delgado RM . Mechanical circulatory support for advanced heart failure (where does it stand in 2003?) . Circulation . 2003;108:3064–3068
  23. Goldstein D , Oz M , Rose E . Implantable left ventricular assist devices . N Engl J Med . 1998;339:1522–1533
  24. Morgan JA , John R , Rao V , Oz MC , Naka Y . Bridging to transplant with the HeartMate left ventricular assist device (the Columbia Presbyterian 12-year experience) . J Thorac Cardiovasc Surg . 2004;127:1309–1316
  25. DiBella I , Pagani FC , Banfi C . Results with the Novacor assist system and evaluation of long-term assistance . Eur J Cardiothorac Surg . 2000;18:112–116
  26. Deng MC , Edwards LB , Hertz MI , et al.   Mechanical circulatory support device database of the International Society of Heart and Lung Transplantation (third annual report) . J Heart Lung Transplant . 2005;24:1182–1187
  27. Park SJ , Bank AJ , Miller LW . Left ventricular assist device bridge therapy for acute myocardial infarction . Ann Thorac Surg . 2000;69:1146–1151
  28. Dang NC , Topkara VK , Leache MD , et al.   Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock (a two center study) . J Thorac Cardiovasc Surg . 2005;130:693–699
  29. Park SJ , Tector A , Picconi W , Gelijns A , et al.   Left ventricular assist devices as permanent heart failure therapy (a new look at survival) . J Thorac Cardiovasc Surg . 2005;129:9–17
  30. Lietz K , Long J , Slaughter MS , Miller L . Preoperative risk factors for early mortality following use of left ventricular assist devices as destination therapy for end stage heart failure . Circulation . 2005;XX(suppl):
  31. Lietz K, Miller LW Use of a preoperative risk score for mortality after left ventricular assist device implantation as an alternative to transplantation: implications for patient selection. N Engl J Med (in press).
  32. Long JW , Kfoury AG , Slaughter MS , et al.   Long-term destination therapy with the HeartMate XVE left ventricular assist device (improved outcomes since the REMATCH trial) . Congest Heart Fail . 2005;11:133–138
  33. Reedy JE , Swartz MT , Miller LW , Pennington DG . Bridge to transplantation (importance of patient selection) . J Heart Lung Transplant . 1990;9:473–480
  34. Farrar DJ . Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to transplantation . J Heart Lung Transplant . 1994;13:93–100
  35. Stevenson LW . Patient selection for mechanical bridging to transplantation . Ann Thorac Surg . 1996;61:380–387
  36. Aaronson KD , Patel H , Pagani FD . Patient selection for left ventricular assist device therapy . Ann Thorac Surg . 2003;75(suppl 6):29–35
  37. Miller LW . Patient selection for the use of ventricular assist devices as a bridge to transplantation . Ann Thorac Surg . 2003;75(suppl 6):66–71
  38. Rao V , Oz MC , Flannery MA , Naka Y , et al.   Revised screening scale to predict survival after insertion of a left ventricular assist device . J Thorac Cardiovasc Surg . 2003;125:855–862
  39. Bank AJ , Mir SH , Bolman RM , et al.   Effects of left ventricular assist devices on outcome in patients undergoing heart transplantation . Ann Thorac Surg . 2000;69:1369–1374
  40. Dowling RD , Park SJ , Pagani FD , et al.   HeartMate VE LVAS design enhancements and its impact on device reliability . Eur J Cardiothorac Surg . 2004;25:958–963
  41. Pagani FD, Long JW, Dembitsky WP, Joyce LD, Miller LW. Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Ann Thorac Surg (in press).
  42. Birks E , Tansley P , Yacoub M , et al.   Incidence and clinical management of life- threatening left ventricular assist device failure . J Heart Lung Transplant . 2004;23:964–969
  43. Horton SC , Khodaverdian R , Powers A , et al.   Left ventricular assist device malfunction (a systematic approach to diagnosis) . J Am Coll Cardiol . 2004;43:1574–1583
  44. Holman WL , Park SJ , Long JW , et al.  REMATCH investigators   Infection in permanent circulatory support (experience from the REMATCH trial) . J Heart Lung Transplant . 2004;23:1359–1365
  45. Chinn R , Dembitsky W , Eaton L , et al.   Multicenter experience (prevention and management of left ventricular assist device infections) . ASAIO J . 2005;51:461–470
  46. Kalman H , Dembitsky L , Eaton S , et al.   Nutrition assessment and management of left ventricular assist device patients . J Heart Lung Transplant . 2005;24:1690–1696
  47. Miller LW . Listing criteria for heart transplantation (results of an American Society of Transplant Physicians—NIH conference) . Transplantation . 1998;66:947–951
  48. Mancini D , Aaronson K . Peak VO2 (a simple yet enduring standard) . Circulation . 2000;101:1080–1082
  49. Osada N , Chaitman BR , Miller LW , Wolford TL . Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation . JAMA . 1998;31:577–582
  50. Stelken AM , Younis L , Miller LW , Chaitman BR . Prognostic value of cardiopulmonary exercise using percent achieved of predicted peak oxygen consumption for patients with ischemic and dilated cardiomyopathy . J Am Coll Cardiol . 1996;27:345–352
  51. Medicare national coverage determinations manual. Chapter 1. Part 1. Section 20.9. Artificial heart and related devices. Centers for Medicare and Medicaid Services (CMS) 2003 http://www.cms.hhs.gov.manuals/103_cov_determ/ncd103cl-Part 1.pdf
  52. Centers for Medicare and Medicaid Services . Medicare approved LVAD destination therapy facilities . 2005; Accessed April 18, 2005. http://www.cms.hhs.gov/coverage/map/lvadfacilityrev4.asp
  53. Stevenson LW , Miller LW , Desvigne-Nickens P , et al.   Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy (a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)) . Circulation . 2004;110:975–981
  54. Hershberger RE , Nauman D , Walker TL , Dutton D , Burgess D . Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory end stage heart failure . J Cardiac Fail . 2003;9:180–187
  55. Stevenson LW . Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: Chronic inotropic therapy . Circulation . 2003;108:492–497
  56. Jaski BE , Kim JC , Naftel DC , et al.   Cardiac transplant outcome of patients supported on a left ventricular assist device vs intravenous inotropic therapy . J Heart Lung Transplant . 2001;20:449–456
  57. Aaronson KD , Eppinger MJ , Dyke DB , et al.   Left ventricular assist device therapy improves utilization of donor hearts . JAMA . 2002;39:1247–1254
  58. Butler J , Young JB , Abraham WT , Stevenson LW . Beta blocker use and outcomes among hospitalized heart failure patients . J Am Coll Cardiol . 2005;45(suppl A):154
  59. Heywood JT . Cardio-renal syndrome (lessons from the ADHERE database and treatment options) . Heart Fail Rev . 2004;9:195–201
  60. Boerritger G , Burnett JC . Cardio-renal syndrome in decompensated heart failure (prognostic and therapeutic implications) . Curr Heart Fail Rev . 2004;1:113–120
  61. Butler J , Forman DE , Abraham WT , et al.   Relationship between heart failure treatment and development of worsening renal function among hospitalized patients . Am Heart J . 2004;147:331–338
  62. Cockcroft DW , Gault MH . Prediction of creatinine clearance from serum creatinine . Nephron . 1976;16:31–41
  63. Smith GL , Vaccarino V , Watnick SG , Krumholz HM . Worsening renal function (what is a clinically meaningful change in creatinine during hospitalization with heart failure) . J Cardiac Fail . 2003;9:13–25
  64. Bart BA , Boyle A , Bank AJ , et al.   Ultrafiltration versus usual care for hospitalized patients with heart failure (relief for acutely fluid overloaded patients with decompensated heart failure—the RAPID–CHF trial) . J Am Coll Cardiol . 2005;46:2043–2046
  65. Tsukui H , Teuteberg JJ , Murali S , McNamara DM , Kormos RL . Biventricular assist device utilization for patients with morbid congestive heart failure (a justifiable strategy) . Circulation . 2005;(suppl 9):65–72
  66. Kavarana MN , Pessin-Minsley MS , Urtecho J , et al.   Right ventricular dysfunction and organ failure in left ventricular assist device recipients (a continuing problem) . Ann Thorac Surg . 2002;73:745–753
  67. Ochiai Y , McCarthy PM , Smedira NG . Predictors of severe right ventricular failure after implantable left ventricular assist device insertion (analysis of 245 patients) . Circulation . 2002;106(suppl):198–202
  68. Firth JD , Raine AE , Ledingham JG . Raised venous pressure. A direct cause of renal sodium retention in edema . Lancet . 1988;1:1033–1035
  69. Goldstein DJ , Seldomridge JA , Chen JM , et al.   Left ventricular assist device and bleeding (adding insult to injury) . Ann Thorac Surg . 1995;59:1063–1068
  70. Dewald O , Schmitz DO , Reichart B , et al.   Platelet activation markers in patients with heart assist devices . Artif Organs . 2005;29:292–299
  71. Pasini E . Cachexia in chronic heart failure patients . Italian Heart J . 2003;4:232–235
  72. Engelman DJ . Impact of body mass index (BMI) and albumin on morbidity and mortality after cardiovascular surgery . J Thorac Cardiovasc Surg . 1999;118:866–873
  73. Reeves BC , Ascione R , Chamberlain MH , Angelini GD . Effect of body mass index on early outcomes in patients undergoing coronary bypass surgery . J Am Coll Cardiol . 2003;42:668–676
  74. Lilippatos GS, Anker SD, Kremastinos DT. Pathophysiology of peripheral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care 8:249–54.
  75. Sharma R , Anker SD . Cytokines, apoptosis, and cachexia (the potential for TNF antagonism) . Int J Cardiol . 2002;85:161–171
  76. Lund L , Aaronson KD , Mancini DM . Validation of peak exercise oxygen consumption and the heart failure survival score for serial risk stratification in advanced heart failure . Am J Cardiol . 2005;95:734–741
  77. Bostic RR . Heart transplant and left ventricular assist device costs . J Heart Lung Transplant . 2005;24:1997–1998
  78. Stevenson LW , Kormos RL , Bourge RC , et al.   Mechanical cardiac support 2000 (current applications and future trial design) . JAMA . 2001;37:340–370

PII: S1053-2498(06)00247-6

doi: 10.1016/j.healun.2006.03.007

The Journal of Heart and Lung Transplantation
Volume 25, Issue 7 , Pages 756-764 , July 2006

Article Tools